Condition: Postpartum Hypertension (PPHT) · Sponsor: University of California, Los Angeles
This randomized controlled trial compares two common medications, labetalol and extended-release nifedipine, to determine which is more effective at managing postpartum high blood pressure. We hypothesize that extended-release nifedipine will better control blood pressure and reduce the need for continued medication beyond six weeks postpartum. The study will enroll 110 postpartum participants, randomly assigning them to one of the two medications, with remote blood pressure monitoring to evaluate treatment effectiveness and inform postpartum hypertension management.
This description comes directly from the study's public registry record.
Tina A Nguyen, MD · 310-794-7274 · tinaanguyen@mednet.ucla.edu
Sonia S Raghuram, MS · 408-896-8704 · sraghuram@mednet.ucla.edu
Always discuss trial participation with your own doctor first.
| UCLA Ronald Reagan | Los Angeles, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06915792